Antifungal dosing in critically ill patients

被引：1
|
作者：
Bergman S.J. [1 ]
Tyagi I. [1 ]
Ronald K. [1 ]
机构：
[1] Division of Infectious Diseases, Southern Illinois University School of Medicine, Springfield, IL 62794, 701 North 1st Street
来源：
Current Fungal Infection Reports | 2010年 / 4卷 / 2期
关键词：
Amphotericin B; Anidulafungin; Antifungals; Caspofungin; Combinations; Critical care; Dose; Echinocandin; Fluconazole; Flucytosine; ICU; Itraconazole; Lipid formulations; Micafungin; Pharmacodynamics; Pharmacokinetics; Posaconazole; Triazole; Voriconazole;
D O I：
10.1007/s12281-010-0012-z
中图分类号：
学科分类号：
摘要：
This article reviews appropriate dosing for antifungals and emphasizes factors specific to the critically ill patient, along with drug pharmacokinetics and pharmacodynamics. The rationale for doses of the echinocandins (caspofungin, micafungin, anidulafungin), triazoles (fluconazole, voriconazole, itraconazole, posaconazole), amphotericin B (including lipid formulations), and flucytosine are discussed. © 2010 Springer Science+Business Media, LLC.
引用
收藏
页码：78 / 86
页数：8
相关论文
共 50 条
  • [1] Antifungal Dosing Strategies for Critically Ill Patients
    Dietrich T.E.
    Pfeifer C.J.
    Aker K.E.
    Bergman S.J.
    [J]. Current Fungal Infection Reports, 2017, 11 (1) : 5 - 15
  • [2] Antifungal Dosing in Critically Ill Patients on Extracorporeal Membrane Oxygenation
    Haifa Lyster
    Kiran Shekar
    Kevin Watt
    Anna Reed
    Jason A. Roberts
    Mohd-Hafiz Abdul-Aziz
    [J]. Clinical Pharmacokinetics, 2023, 62 : 931 - 942
  • [3] Antifungal Dosing in Critically Ill Patients on Extracorporeal Membrane Oxygenation
    Lyster, Haifa
    Shekar, Kiran
    Watt, Kevin
    Reed, Anna
    Roberts, Jason A. A.
    Abdul-Aziz, Mohd-Hafiz
    [J]. CLINICAL PHARMACOKINETICS, 2023, 62 (07) : 931 - 942
  • [4] Gentamicin dosing in critically ill patients
    Hansen, M
    Christrup, LL
    Jarlov, JO
    Kampmann, JP
    Bonde, J
    [J]. ACTA ANAESTHESIOLOGICA SCANDINAVICA, 2001, 45 (06) : 734 - 740
  • [5] Antifungal stewardship in critically ill patients
    Gennaro De Pascale
    Ignacio Martin-Loeches
    Saad Nseir
    [J]. Intensive Care Medicine, 2023, 49 : 681 - 684
  • [6] Antifungal prophylaxis in critically ill patients
    Silvestri, Luciano
    Zandstra, Durk F.
    van Saene, Hendrick K. F.
    Petros, Andy J.
    Thyagarajan, Sujatha
    de la Cal, Miguel A.
    Thomann, Corrado
    [J]. CRITICAL CARE, 2008, 12 (03):
  • [7] Antifungal stewardship in critically ill patients
    De Pascale, Gennaro
    Martin-Loeches, Ignacio
    Nseir, Saad
    [J]. INTENSIVE CARE MEDICINE, 2023, 49 (06) : 681 - 684
  • [8] Antifungal prophylaxis in critically ill patients
    Luciano Silvestri
    Durk F Zandstra
    Hendrick KF van Saene
    Andy J Petros
    Sujatha Thyagarajan
    Miguel A de la Cal
    Corrado Thomann
    [J]. Critical Care, 12
  • [9] Using pharmacokinetics and pharmacodynamics to optimise dosing of antifungal agents in critically ill patients: a systematic review
    Sinnollareddy, Mahipal
    Peake, Sandra L.
    Roberts, Michael S.
    Lipman, Jeffrey
    Roberts, Jason A.
    [J]. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2012, 39 (01) : 1 - 10
  • [10] DOSING PROBLEMS OF GENTAMICIN IN CRITICALLY ILL PATIENTS
    REGAZZI, BM
    RONDANELLI, R
    DIONIGI, RV
    MAPELLI, A
    GASATI, A
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY RESEARCH, 1986, 6 (05) : 355 - 359
12345